Clinical trials are the backbone of medical evidence. They are the process by which a treatment goes from "this might work" to "we have strong evidence that this works." For cannabis, clinical trials are especially important because decades of federal restrictions have left us with far fewer rigorous studies than we need. The more people who participate in cannabis clinical trials, the faster we close the evidence gap.

How Clinical Trials Work

Clinical trials are research studies that test how well a medical approach works in people. They follow a structured process designed to protect participants while generating reliable evidence. Most clinical trials move through four phases:

Phase I: Is It Safe?

The first phase tests a treatment in a small group of people (typically 20 to 80 participants) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. Phase I trials are not trying to prove the treatment works — they are trying to establish that it does not cause unacceptable harm at various doses.

• Participants: Usually healthy volunteers or patients who have exhausted other treatments
• Duration: Several months
• Success rate: About 70% of treatments pass Phase I

Phase II: Does It Work?

Phase II expands the study to a larger group (typically 100 to 300 participants) and focuses on whether the treatment actually produces the desired therapeutic effect. Researchers also continue monitoring safety and begin to refine the optimal dosage.

• Participants: People with the specific condition being studied
• Duration: Several months to two years
• Success rate: About 33% of treatments pass Phase II

Phase III: Is It Better Than What We Have?

Phase III studies involve large groups (typically 1,000 to 3,000 participants) and compare the new treatment against existing treatments or a placebo. These are the gold-standard randomized controlled trials (RCTs) that produce the strongest evidence. Most FDA drug approvals are based on successful Phase III trials.

• Participants: Large, diverse groups with the target condition
• Duration: One to four years
• Success rate: About 25-30% of treatments pass Phase III

Phase IV: Long-Term Monitoring

After a treatment is approved, Phase IV trials continue to monitor it in the general population. These studies track long-term safety, identify rare side effects that may not have appeared in smaller trials, and explore how the treatment performs across different demographic groups.

• Participants: General patient populations
• Duration: Ongoing
• Purpose: Real-world safety and effectiveness monitoring

How to Find Cannabis Clinical Trials

If you are interested in participating in cannabis research — or simply want to know what is currently being studied — several resources can help.

ClinicalTrials.gov

The most comprehensive resource for finding clinical trials is ClinicalTrials.gov, a database maintained by the U.S. National Library of Medicine. It lists over 400,000 clinical studies from around the world, including hundreds of active cannabis trials.

How to search:

1. Visit ClinicalTrials.gov
2. In the search bar, enter terms like "cannabis," "cannabinoid," "CBD," "THC," or "marijuana" along with your condition of interest (e.g., "cannabis chronic pain")
3. Use the filters to narrow results:
   • Status: Select "Recruiting" to find trials currently accepting participants
   • Location: Filter by your state or country
   • Phase: Filter by trial phase if desired
4. Each listing includes eligibility criteria, study locations, contact information, and a plain-language summary of what the study involves

Other Resources for Finding Trials

• Your state's medical cannabis program: Some state programs maintain lists of approved research studies or can direct you to local opportunities.
• University research centers: Many major universities now have dedicated cannabis research programs. Check the websites of academic medical centers in your area.
• Your healthcare provider: If you have a doctor who is knowledgeable about cannabis, they may be aware of trials recruiting in your area or condition.
• Americans for Safe Access: This patient advocacy organization maintains resources about research opportunities.

How to Participate in a Clinical Trial

Participating in a clinical trial is a significant decision. Here is what the process typically looks like:

Step 1: Determine Eligibility

Every trial has specific eligibility criteria — requirements you must meet to participate. Common criteria include:

• Age range (most require participants to be 21+)
• Specific medical condition or diagnosis
• Current medication requirements (some trials require you to be on certain medications; others require you to be off them)
• Medical history (prior cannabis use, mental health history, pregnancy status, etc.)
• Geographic proximity to the study site

Step 2: Informed Consent

Before enrolling, you will go through an informed consent process. The research team will explain:

• The purpose of the study
• What you will be asked to do (dosing schedules, assessments, follow-up visits)
• Potential risks and side effects
• Whether a placebo is involved (you might receive the treatment or an inactive substance)
• Your right to withdraw at any time without penalty
• How your data will be protected

Step 3: The Study Itself

What you do during a clinical trial depends entirely on the study. You may be asked to:

• Use a specific cannabis product at prescribed doses and times
• Keep a daily diary or journal of symptoms and side effects
• Attend regular check-in appointments (in-person or virtual)
• Complete questionnaires or assessments
• Provide blood, urine, or saliva samples
• Undergo medical exams or cognitive testing

Step 4: Follow-Up

After the active phase of the study, there is usually a follow-up period where researchers check on your health and track any lasting effects. Some studies also share their results with participants once the research is complete.

What to Expect: Common Questions

Will I receive cannabis or a placebo?

Many clinical trials are "randomized" and "double-blind," meaning participants are randomly assigned to receive either the actual treatment or an inactive placebo, and neither the participants nor the researchers know who received what until the study ends. This design is critical for eliminating bias, but it does mean you might not receive the active treatment. Some trials use an "open-label" design where everyone receives the treatment — check the study description to understand the design.

Will it cost me anything?

In most clinical trials, the study treatment and related medical tests are provided at no cost to you. Many trials also compensate participants for their time and travel. However, some trials may not cover costs related to your underlying condition that are not part of the study. Ask the research team about all costs before enrolling.

Is it legal?

Federally approved clinical trials involving cannabis operate under legal protections. Researchers have DEA licenses to handle Schedule I substances for research purposes. Participating in an approved clinical trial does not put you at legal risk, even in states where cannabis is not otherwise legal.

Will my employer or insurance company know?

Clinical trial participation is protected by strict privacy regulations (including HIPAA). However, if you are concerned about drug testing by an employer, discuss this with the research team before enrolling — some cannabis trials may result in detectable THC levels in standard drug tests.

Current Areas of Active Research

Cannabis clinical trials are currently underway across a wide range of conditions and questions. Some of the most active areas include:

Why Participation Matters

Every clinical trial that enrolls enough participants and produces results — positive or negative — helps close the evidence gap. Negative results are just as valuable as positive ones: they help us understand what cannabis does not do and prevent future patients from pursuing ineffective treatments.

If you are already using cannabis for a health condition, you may be an ideal candidate for a clinical trial. Your participation would not only contribute to the broader scientific understanding of cannabis, but could also give you access to medical-grade products, expert monitoring, and cutting-edge treatment approaches at no cost.